• Product nameAnti-ADAM33 antibody
    See all ADAM33 primary antibodies
  • Description
    Goat polyclonal to ADAM33
  • SpecificityThis antibody is expected to recognise isoform alpha (NP_079496) and not isoform beta (NP_694882).
  • Tested applicationsSuitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide:


    , corresponding to Internal sequence amino acids 637-650 of Human ADAM33



Our Abpromise guarantee covers the use of ab36172 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesPeptide ELISA: Antibody detection limit dilution 1:64,000.
    WB: Use at a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 88 kDa.
    Experiments gave bands at approx 80-90kDa and strong ladder from 26 to 38kDa in Human Prostate lysates after 0.3ug/ml antibody staining. The observation of multiple bands and the 38 kDa band correspond to earlier findings in literature (Powell et al, Am J Respir Cell Mol Biol. 2004 Jul;31(1):13-21; PMID: 14742294).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Tissue specificityExpressed in all tissues, except liver, with high expression in placenta, lung, spleen and veins.
    • Involvement in diseaseGenetic variations in ADAM33 are associated with susceptibility to asthma (ASTHMA) [MIM:600807]. The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with weezing due to spasmodic contraction of the bronchi.
    • Sequence similaritiesContains 1 disintegrin domain.
      Contains 1 EGF-like domain.
      Contains 1 peptidase M12B domain.
    • DomainThe conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
    • Post-translational
      The precursor is cleaved by a furin endopeptidase.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • A disintegrin and metalloprotease 33 antibody
      • A disintegrin and metalloproteinase domain 33 antibody
      • ADA33_HUMAN antibody
      • ADAM 33 antibody
      • ADAM metallopeptidase domain 33 antibody
      • ADAM33 antibody
      • C20orf153 antibody
      • Disintegrin and metalloproteinase domain-containing protein 33 antibody
      • Disintegrin and reprolysin metalloproteinase family protein antibody
      • DJ964F7.1 antibody
      • DKFZp434K0521 antibody
      • FLJ35308 antibody
      • FLJ36751 antibody
      • Metalloprotease disintegrin antibody
      • MGC149823 antibody
      • MGC71889 antibody
      • PRO1891 antibody
      • UNQ873 antibody
      see all

    Anti-ADAM33 antibody images

    • All lanes : Anti-ADAM33 antibody (ab36172) at 0.3 µg/ml

      Lane 1 : Human Prostate lysate (35µg protein in RIPA buffer) with no blocking from immunizing peptide
      Lane 2 : Human Prostate lysate (35µg protein in RIPA buffer) with blocking from immunizimg peptide

      Predicted band size : 88 kDa

    References for Anti-ADAM33 antibody (ab36172)

    This product has been referenced in:
    • Kim KE  et al. Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer. J Immunol 182:3548-55 (2009). WB ; Human . Read more (PubMed: 19265133) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab36172.
    Please use the links above to contact us or submit feedback about this product.